Fonadelpar
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02104388)
Timeline
Indications
Mechanism of action
- PPAR delta/gammaAGONIST
PPAR delta/gamma agonist
Peroxisome proliferator-activated receptor delta agonist
Chemistry & pharmacology
Loading structure…
SMILES
Cc1cc2c(CCc3sc(-c4ccc(C(F)(F)F)cc4)nc3C(C)C)noc2cc1OCC(=O)O- Mol. weight
- 504.53 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545186 ↗
Also known as
- sjp-0035
- sjp-0035
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03527212 | Phase 3 | Aug 31, 2018 | Senju Pharmaceuticals |
| NCT02929823 | Phase 2 | Sep 1, 2016 | Senju Pharmaceuticals |
| NCT02104388 | Phase 2 | Mar 1, 2014 | Senju Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Senju Pharmaceuticals | For profit | 3 | 3 | 2 | 2014 |
1 organizations
Page 1 / 1